New Products: Imaging system that helps detect cervical Ca approved by FDA
FDA has approved imaging system to help detect cervical cancer.
BD says reducing false-negative findings and interpretation errors is the system's goal. That's accomplished through "state-of-the-art" guided screening technology for rapidly relocating the fields of view that the system identifies as likeliest to contain cells of interest.
For more information, visit the company's Web site at http://www.bd.com/.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
